Diamedica therapeutics inc. (DMAC)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Dec'17
Current assets:
Cash and cash equivalents

3,300

3,883

4,741

2,974

2,759

16,823

-

Marketable securities

9,348

3,995

5,002

7,992

10,958

-

-

Cash

-

-

-

-

-

-

1,353

Amounts receivable

985

823

664

1,112

929

780

80

Prepaid expenses and other assets

337

47

89

198

298

369

-

Deposits

195

88

310

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

61

Total current assets

14,165

8,836

10,806

12,276

14,944

17,972

1,494

Non-current assets:
Operating lease right-of-use asset

140

153

165

177

189

-

-

Property and equipment, net

60

64

68

73

90

96

37

Deposits

-

-

-

271

271

271

271

Total non-current assets

200

217

233

521

550

367

308

Total assets

14,365

9,053

11,039

12,797

15,494

18,339

1,802

Current liabilities:
Accounts payable

444

182

312

262

685

483

-

Accrued liabilities

435

1,076

837

630

686

808

-

Finance lease obligation

6

6

5

5

5

5

-

Operating lease obligation

50

54

51

50

49

-

-

Accounts payable and accrued liabilities

-

-

-

-

-

-

919

Warrant liability

-

-

-

-

-

-

84

Total current liabilities

935

1,318

1,205

947

1,425

1,296

1,003

Non-current liabilities:
Finance lease obligation, non-current

11

13

14

15

17

18

-

Operating lease obligation, non-current

96

105

120

133

146

-

-

Total non-current liabilities

107

118

134

148

163

18

-

Shareholders’ equity:
Paid-in capital

72,323

64,232

63,831

63,380

63,123

62,993

41,033

Accumulated other comprehensive income

42

2

6

11

3

-

-

Accumulated deficit

-59,042

-56,617

-54,137

-51,689

-49,220

-45,968

-40,234

Total shareholders’ equity

13,323

7,617

9,700

11,702

13,906

17,025

799

Total liabilities and shareholders’ equity

14,365

9,053

11,039

12,797

15,494

18,339

1,802